Navina key facts
as of Oct 2026- Developer of a healthcare platform designed to transform the way clinicians interact with patient data to enhance care delivery.
- Navina is valued at approximately $290.0M as of Oct 2026 (last reported valuation).
- It has raised $99.0M; the latest was Later Stage VC ($55.0M) in Mar 2025.
- Notable investors include Goldman Sachs Growth Equity, Vertex Ventures Israel, Schusterman Family Investments, ALIVE Israel Healthtech Fund, ELQ Investors VIII — 8 tracked in total.
- Status: Privately Held (backing).
Navina's last reported valuation, Mar 2025. Nothing priced has surfaced since.
- ·Watch Navina: the Monday email on marks, rounds and moves
Navina funding rounds
No funding rounds for Navina are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Navina valuation
Navina's last reported valuation was $290 million in Mar 2025. No priced round, secondary trade or fund mark has surfaced since.
Navina investors
8 investors are on record for Navina, including Goldman Sachs Growth Equity, Vertex Ventures Israel, Schusterman Family Investments and ALIVE Israel Healthtech Fund.
About Navina
Developer of a healthcare platform designed to transform the way clinicians interact with patient data to enhance care delivery. The company's platform aggregates data from multiple sources applies machine learning to identify conditions and care gaps, offers transparent explanations linked to original records, and integrates seamlessly into existing workflows, enabling healthcare providers to streamline administration, improve diagnostic accuracy, enhance risk assessment, and optimize patient care.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2018
- Employees
- 177
- Website
- navina.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.